Cargando…

Clinical management of chronic hepatitis B: A concise overview

Worldwide, over 250 million people are chronically infected with the hepatitis B virus (HBV). Infected patients have an up to 100‐fold increased risk for liver‐related complications, including cirrhosis, hepatic decompensation and hepatocellular carcinoma. Nonetheless, the majority of the infections...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furquim d’Almeida, Arno, Ho, Erwin, Van Hees, Stijn, Vanwolleghem, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Hepatobiliary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830276/ https://www.ncbi.nlm.nih.gov/pubmed/34846093 http://dx.doi.org/10.1002/ueg2.12176

Ejemplares similares

Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center
por: Jachs, Mathias, et al.
Publicado: (2023)

Liver cT(1) decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus
por: Jayaswal, Arjun N. A., et al.
Publicado: (2020)

Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance
por: Mähringer‐Kunz, Aline, et al.
Publicado: (2021)

Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
por: Van Hees, Stijn, et al.
Publicado: (2016)

Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1
por: Biewenga, Maaike, et al.
Publicado: (2021)

The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis
por: Saleh, Zachary M., et al.
Publicado: (2021)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard
por: von Ulmenstein, Sophie, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
por: Duengelhoef, Paul, et al.
Publicado: (2022)

Multidetector computed tomography assessment of venous invasion in hepatic alveolar echinococcosis
por: Zhang, Tieliang, et al.
Publicado: (2022)

Higher frequency of hepatic steatosis at CT among COVID-19-positive patients
por: Medeiros, Augusto Kreling, et al.
Publicado: (2020)

The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion
por: Liu, Jianwei, et al.
Publicado: (2023)

Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis
por: Jachs, Mathias, et al.
Publicado: (2021)

Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022)

Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients
por: Owusu Sekyere, Solomon, et al.
Publicado: (2021)

Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute‐on‐chronic liver failure
por: Balcar, Lorenz, et al.
Publicado: (2021)

Management of pregnancy in women with cirrhosis
por: Rahim, Mussarat N., et al.
Publicado: (2021)

Assessment of dynamic hepatic and renal imaging changes in COVID-19 survivors using T1 mapping and IVIM-DWI
por: Han, Qiuyue, et al.
Publicado: (2022)

The natural course of giant paraesophageal hernia and long-term outcomes following conservative management
por: Oude Nijhuis, Renske A B, et al.
Publicado: (2020)

Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV
por: Vanwolleghem, Thomas, et al.
Publicado: (2021)

Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient‐centered program from Italy
por: Mangia, Alessandra, et al.
Publicado: (2021)

Patient reported outcome measure thresholds: The next step in the management of polycystic liver disease
por: Duijzer, Renée, et al.
Publicado: (2023)

Gallbladder polyps growth rate is an independent risk factor for neoplastic polyps
por: Han, Ji Won, et al.
Publicado: (2022)

Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Müller, Lukas, et al.
Publicado: (2021)

Dynamic contrast-enhanced CT and clinical features of sarcomatoid hepatocellular carcinoma
por: He, Guangming, et al.
Publicado: (2023)

Can we predict the future of patients with liver cirrhosis using volumetrics?
por: Lantinga, Marten A., et al.
Publicado: (2022)

CT of amebic liver abscess: different morphological types with different clinical features
por: Priyadarshi, Rajeev Nayan, et al.
Publicado: (2021)

Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance
por: Zimmermann, Lisa, et al.
Publicado: (2021)

Clinical application of the contrast-enhancement boost technique in computed tomography angiography of the portal vein
por: Hou, Juan, et al.
Publicado: (2022)

Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma
por: Wei, Xiaolin, et al.
Publicado: (2023)

Questionnaire PLD‐complaint‐specific assessment identifies need for therapy in polycystic liver disease: A multi‐centric prospective study
por: Billiet, Antoon, et al.
Publicado: (2023)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

Indeterminate pediatric acute liver failure: Clinical characteristics of a temporal cluster of five children in the Netherlands in the spring of 2022
por: Lexmond, Willem S., et al.
Publicado: (2022)

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
por: Pal Chaudhary, Surendra, et al.
Publicado: (2023)

Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review
por: Hadefi, Alia, et al.
Publicado: (2023)

World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
por: de Martel, Catherine, et al.
Publicado: (2015)

Correlation of liver-to-spleen ratio, lung CT scores, clinical, and laboratory findings of COVID-19 patients with two consecutive CT scans
por: Guler, Ezgi, et al.
Publicado: (2020)

Predictors of biliary intervention in patients hospitalized for COVID-19
por: Chen, Christine, et al.
Publicado: (2022)

Liver segmental volume and attenuation ratio (LSVAR) on portal venous CT scans improves the detection of clinically significant liver fibrosis compared to liver segmental volume ratio (LSVR)
por: Obmann, V. C., et al.
Publicado: (2020)

Spectrum of Fontan-associated liver disease assessed by MRI and US in young adolescents
por: Thrane, Karl Julius, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i3pfq67a2bhkcgnq52av3j6eb7